Yun-fan You

Tongji Medical College And State Key Laboratory For Diagnosis And Treatment Of Severe Zoonotic Infectious Diseases
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Erk5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis.

Erk5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 09, 2026

Identification of novel therapeutic targets for cognitive performance and associations with brain health.

Identification of novel therapeutic targets for cognitive performance and associations with brain health.

Journal: Translational psychiatry

Published: May 27, 2024

Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.

Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.

Journal: Science immunology

Published: May 10, 2024

Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway.

Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway.

Journal: Journal of neuroinflammation

Published: May 04, 2024

Bruton's tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia.

Bruton's tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia.

Journal: Journal of neuroinflammation

Published: February 08, 2024

Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy.

Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 30, 2024

Ldl-stimulated microglial activation exacerbates ischemic white matter damage.

Ldl-stimulated microglial activation exacerbates ischemic white matter damage.

Journal: Brain, behavior, and immunity

Published: December 06, 2023

B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.

B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.

Journal: EMBO molecular medicine

Published: September 23, 2023

Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder.

Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder.

Journal: Neuroscience bulletin

Published: July 12, 2023

Trem2 deficiency attenuates microglial phagocytosis and autophagic-lysosomal activation in white matter hypoperfusion.

Trem2 deficiency attenuates microglial phagocytosis and autophagic-lysosomal activation in white matter hypoperfusion.

Journal: Journal of neurochemistry

Published: May 05, 2023

TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder.

TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder.

Journal: Journal of neuroinflammation

Published: February 15, 2023

Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.

Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders.

Journal: Brain : a journal of neurology

Published: December 31, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026